Login
Overview and position on competitiveness
Interview mit Stephan Mumenthaler in PharmaBoardroom
Guest commentary Handelszeitung: Director General Stephan Mumenthaler
Switzerland retains top spot in EU Innovation Scoreboard 2023
Guest commentary NZZ: Director General Stephan Mumenthaler
Saying YES to the implementation of the OECD minimum tax
WTO decision on TRIPS Agreement
Chemical and pharmaceutical industry as a driver of growth
Interview Stephan Mumenthaler: success factors to boost R&D
Swiss innovation needs an efficient patent system
Action plan: One Health approach to combating antimicrobial resistance
Overview and position on antibiotic resistance
Promoting research into new antibiotics - but how?
Containing resistances: Antibiotic monitoring in veterinary medicine
25 years of bilateral agreements: a model of success for Switzerland